<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T16:25:16Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/64298" metadataPrefix="mods">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/64298</identifier><datestamp>2024-12-16T09:01:52Z</datestamp><setSpec>com_10324_1134</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1213</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Gascoigne, Nicholas R. J.</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Casas Requena, Javier</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Brzostek, Joanna</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Rybakin, Vasily</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2024-01-08T14:25:41Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2024-01-08T14:25:41Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2011</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="citation">Frontiers Immunol.  2, (2011).</mods:identifier>
<mods:identifier type="uri">https://uvadoc.uva.es/handle/10324/64298</mods:identifier>
<mods:identifier type="doi">10.3389/fimmu.2011.00072</mods:identifier>
<mods:identifier type="publicationtitle">Frontiers in Immunology</mods:identifier>
<mods:identifier type="publicationvolume">2</mods:identifier>
<mods:identifier type="essn">1664-3224</mods:identifier>
<mods:abstract>Recent data with CD8+T cells show that the initial phase ofT cell receptor (TCR) binding to MHC–peptide (MHCp) is quickly followed by a second, stronger, binding phase representing the binding of CD8 to the MHCp. This second phase requires signaling by a Src-family kinase such as Lck. These data point out two aspects of the initial stage of TCR signaling that have not yet been clearly resolved. Firstly, how and by which Src-family kinase, is the initial phosphorylation of CD3ζ accomplished, given that the Lck associated with the co-receptors (CD4 or CD8) is not yet available. Secondly, what is the mechanism by which the co-receptor is brought close to the bound TCR before the co-receptor binds to MHCp?</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by/4.0/</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">Atribución 4.0 Internacional</mods:accessCondition>
<mods:titleInfo>
<mods:title>Initiation of TCR Phosphorylation and Signal Transduction</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>